Skip to main content
. 2019 Dec 20;122(4):498–505. doi: 10.1038/s41416-019-0683-3

Table 2.

Adverse events observed during follow-up.

Category Overall number of AEs (number of individuals) Rate of AEs: AEs/number of cycles
All toxicities
SAEs 104 (46) 0.29
Grade
 5 5 (5) 0.014
 4 4 (45) 0.011
 3 436 (64) 1.20
 2 876 (70) 2.42
 1 1732 (71) 4.78
Toxicities related to study medicationa
SAEs 18 (8) 0.05
Grade
 5 0 0
 4 0 0
 3 42 (19) 0.12
 2 91 (32) 0.25
 1 166 (47) 0.46

aDesignated as definitely, probably or possibly related to any of the study medications